"Dry Powder Inhalers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A device that delivers medication to the lungs in the form of a dry powder.
| Descriptor ID |
D058995
|
| MeSH Number(s) |
E07.605.500
|
| Concept/Terms |
Dry Powder Inhalers- Dry Powder Inhalers
- Dry Powder Inhaler
- Inhaler, Dry Powder
- Inhalers, Dry Powder
- Powder Inhaler, Dry
- Powder Inhalers, Dry
|
Below are MeSH descriptors whose meaning is more general than "Dry Powder Inhalers".
Below are MeSH descriptors whose meaning is more specific than "Dry Powder Inhalers".
This graph shows the total number of publications written about "Dry Powder Inhalers" by people in this website by year, and whether "Dry Powder Inhalers" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 1 | 0 | 1 |
| 2017 | 3 | 5 | 8 |
| 2018 | 3 | 2 | 5 |
| 2019 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Dry Powder Inhalers" by people in Profiles.
-
Niclosamide inhalation powder made by thin-film freezing: Multi-dose tolerability and exposure in rats and pharmacokinetics in hamsters. Int J Pharm. 2021 Jun 15; 603:120701.
-
Inhaled fixed-dose combination powders for the treatment of respiratory infections. Expert Opin Drug Deliv. 2021 08; 18(8):1101-1115.
-
Development and evaluation of inhalable composite niclosamide-lysozyme particles: A broad-spectrum, patient-adaptable treatment for coronavirus infections and sequalae. PLoS One. 2021; 16(2):e0246803.
-
DuoResp® Spiromax® adherence, satisfaction and ease of use: findings from a multi-country observational study in patients with asthma and COPD in Europe (SPRINT). J Asthma. 2020 10; 57(10):1110-1118.
-
Total emitted dose of salbutamol sulphate at different inhalation flows and inhalation volumes through different types of dry powder inhalers. Exp Lung Res. 2018 May - Jun; 44(4-5):211-216.
-
The pharmacokinetics, pharmacodynamics and tolerability of PUR0200, a novel tiotropium formulation, in chronic obstructive pulmonary disease. Br J Clin Pharmacol. 2018 09; 84(9):2097-2105.
-
Treatment compliance in cystic fibrosis patients with chronic Pseudomonas aeruginosa infection treated with tobramycin inhalation powder: The FREE study. Respir Med. 2018 05; 138:88-94.
-
Patient Satisfaction With Inhaled Medication for Asthma. Respir Care. 2018 07; 63(7):859-864.
-
RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis. Eur Respir J. 2018 01; 51(1).
-
Critical Parameters for Particle-Based Pulmonary Delivery of Chemotherapeutics. J Aerosol Med Pulm Drug Deliv. 2018 06; 31(3):139-154.